133.93
7.59 (6.01%)
| Previous Close | 126.34 |
| Open | 125.08 |
| Volume | 2,752,251 |
| Avg. Volume (3M) | 1,231,514 |
| Market Cap | 3,960,887,808 |
| Price / Earnings (TTM) | 86.41 |
| Price / Earnings (Forward) | 64.52 |
| Price / Sales | 3.26 |
| Price / Book | 4.17 |
| 52 Weeks Range | |
| Earnings Date | 3 Nov 2025 |
| Profit Margin | 7.92% |
| Operating Margin (TTM) | -0.74% |
| Diluted EPS (TTM) | 2.19 |
| Quarterly Revenue Growth (YOY) | 22.70% |
| Quarterly Earnings Growth (YOY) | 138.60% |
| Total Debt/Equity (MRQ) | 5.27% |
| Current Ratio (MRQ) | 9.01 |
| Operating Cash Flow (TTM) | 114.68 M |
| Levered Free Cash Flow (TTM) | 42.41 M |
| Return on Assets (TTM) | 4.40% |
| Return on Equity (TTM) | 10.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Inspire Medical Systems, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.5 |
| Average | -1.63 |
|
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 1.11% |
| % Held by Institutions | 119.04% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 180.00 (Baird, 34.40%) | Buy |
| 180.00 (Wolfe Research, 34.40%) | Buy | |
| Median | 130.00 (-2.93%) | |
| Low | 85.00 (Jefferies, -36.53%) | Hold |
| Average | 137.07 (2.35%) | |
| Total | 10 Buy, 4 Hold | |
| Avg. Price @ Call | 115.95 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 23 Dec 2025 | 91.00 (-32.05%) | Hold | 94.98 |
| Mizuho | 17 Dec 2025 | 130.00 (-2.93%) | Buy | 118.27 |
| RBC Capital | 17 Dec 2025 | 175.00 (30.67%) | Buy | 118.27 |
| 04 Nov 2025 | 125.00 (-6.67%) | Buy | 85.01 | |
| JP Morgan | 16 Dec 2025 | 118.00 (-11.89%) | Hold | 115.51 |
| 04 Nov 2025 | 82.00 (-38.77%) | Hold | 85.01 | |
| Oppenheimer | 08 Dec 2025 | 175.00 (30.67%) | Buy | 143.99 |
| Piper Sandler | 08 Dec 2025 | 165.00 (23.20%) | Buy | 143.99 |
| 04 Nov 2025 | 135.00 (0.80%) | Buy | 85.01 | |
| Baird | 04 Dec 2025 | 180.00 (34.40%) | Buy | 140.03 |
| Morgan Stanley | 02 Dec 2025 | 130.00 (-2.93%) | Hold | 133.93 |
| Truist Securities | 26 Nov 2025 | 165.00 (23.20%) | Buy | 127.33 |
| 04 Nov 2025 | 84.00 (-37.28%) | Hold | 85.01 | |
| Wolfe Research | 25 Nov 2025 | 180.00 (34.40%) | Buy | 130.39 |
| Stifel | 24 Nov 2025 | 110.00 (-17.87%) | Buy | 117.29 |
| Wells Fargo | 04 Nov 2025 | 90.00 (-32.80%) | Buy | 85.01 |
| Jefferies | 24 Oct 2025 | 85.00 (-36.53%) | Hold | 77.52 |
| Evercore ISI Group | 07 Oct 2025 | 125.00 (-6.67%) | Buy | 76.82 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |